The world is experiencing what many experts describe as the golden age of cannabis research. Never before have so many studies, trials, and scientific inquiries been dedicated to understanding the cannabis plant and its applications. A quick look at the U.S. National Library of Medicine’s PubMed database underscores this trend: a search for the term “marijuana” now returns more than 53,000 peer-reviewed entries, reflecting an extraordinary surge in global scientific activity.
Brazil has emerged as a notable contributor to this momentum. Interest in cannabis research within the country has grown significantly in recent years, and a newly granted federal authorization is poised to accelerate Brazil’s scientific output even further.
According to Reuters, Brazil’s prominent agricultural research institution Embrapa has received authorization from the national health agency Anvisa to conduct comprehensive research on the cannabis plant. The approval represents a major milestone for a nation known as one of the world’s top agricultural powerhouses and brings Brazil closer to eventually permitting cannabis cultivation.
Embrapa researcher Daniela Bittencourt described the authorization as a historic step. The approval allows the agency to establish its first cannabis seed bank, as well as launch research programs focused on genetic improvement of the plant for a wide range of potential applications.
The authorization also includes research on industrial hemp, and the program is backed by funding earmarked for at least 12 years of scientific work. Embrapa initially submitted its request in September 2024, and under the newly approved plan, researchers will receive an initial $2.41 million to begin their work.
With a long-term research framework and substantial public investment now in place, Brazil is positioning itself to play a significant role in the future of global cannabis science.
